Manuscripts
Showing 1545 manuscripts.
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants
Citation
Daniel A. Enquobahrie, Lynda Stranix-Chibanda, Barbra A. Richardson, Anneke C. Hesseling, Sarah Bradford, Linda Aurpibul, Grace Montepiedra, Tapiwa Mbengeranwa, Blandina T. Mmbaga, Amita Gupta, Tapiwa Mbengeranwa, Grace John-Stewart, Gaerolwe Masheto, IMPAACT P1078 TB APPRISE Study Team, Patrick Jean–Phillippe, Nahida Chakhtoura, Gerhard Theron, Adriana Weinberg, Haseena Cassim, Mpho S. Raesi, Elsie Jean, Ashenafi S. Cherkos, Deo Wabwire, Sylvia M. LaCourse, Teacler Nematadzira. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants. PMID: 36969345Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial
Citation
Camlin Tierney, Maxensia Owor, Sufia Dadabhai, Avy Violari, Gerhard Theron, Dhayendre Moodley, Cynthia Mukwasi-Kahari, Kathleen George, John Shepherd, George K. Siberry, Renee Browning, Mary Glenn Fowler, Lynda Stranix-Chibanda, IMPAACT P1084s Study Team, Tichaona Vhembo, Kristin Baltrusaitis. Bone and renal health in infants with or without breastmilk exposure to tenofovir-based maternal antiretroviral treatment in the PROMISE randomized trial. Journal of AIDS. PMID: 37199427Journal
Journal of AIDS
Study
P1084s
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings
Citation
Landon Myer, Milton C. Weinstein, Valériane Leroy, Elizabeth J. McFarland, Kenneth A. Freedberg, Andrea L. Ciaranello, Caitlin M. Dugdale, Ogochukwu Ufio, Christopher Alba, Sallie R. Permar, Lynda Stranix-Chibanda, Coleen K. Cunningham, Genevieve G. Fouda. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis among known HIV-exposed infants in resource-limited settings. Journal of International AIDS Society. PMID: 36604316Journal
Journal of International AIDS Society
Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial
Citation
Neaka Mohtashemi, Hannah Ship, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Mary Glenn Fowler, Marion G Peters, Judith S. Currier, Debika Bhattacharya, Camlin Tierney, Kevin Butler, Flavia Matovu Kiweewa, Dhayendre Moodley, Vani Govender, Tichaona Vhembo. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Obstetrics and Gynecology. PMID: 37535953Journal
Obstetrics and Gynecology
Study
1077BF, 1077FF
Micronutrients and Nutritional Status among Children living with HIV with and without Severe Acute Malnutrition: IMPAACT P1092
Citation
Renee Browning, John Moye, Tichaona Vhembo, James S. Ngocho, Macpherson Mallewa, Lameck Chinula, Philippa Musoke, Maxensia Owor, IMPAACT P1092 Team, Mutsa Bwakura-Dangarembizi, Lauren Ziemba, Camlin Tierney, Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello. Micronutrients and Nutritional Status among Children living with HIV with and without Severe Acute Malnutrition: IMPAACT P1092. BMC Nutrition. PMID: 37919816Journal
BMC Nutrition
Study
P1092
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents
Citation
Theodore Ruel, David Burger, Andrew Wiznia, Edward P. Acosta, Lee Fairlie, Rajendra Singh, Lucy Koech, IMPAACT P1093 and ODYSSEY (PENTA 20) Study Teams, Mutsawashe Bwakura-Dangarembizi, Hilda Mujuru, Adeodata R. Kekitiinwa, Cissy M. Kityo, Carmelita Alvero, Hardik Chandasana, Mona Farhad, Mita Thapar, Rohan Hazra, Siobhan Hayes, Ellen Townley, Mark Baker, Ann Buchanan, Diana M Gibb, Pauline Bollen, Anna Turkova, Hylke Waalewijn, Deborah Ford, Angela Colbers. Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. Clinical Pharmacokinetics. 62: 1445-1459. PMID: 37603217Journal
Clinical Pharmacokinetics
Study
P1093
Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children
Citation
Audrey Chang, Andrew Wiznia, Theodore D. Ruel, Edward P. Acosta, IMPAACT 1093 Team, Stephen A. Spector, Sean S. Brummel. Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Journal of Acquired Immune Deficiency Syndromes. 95: doi: 10.1097/QAI.000000000000335. PMID: 38180896Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1093
Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics
Citation
Ellen Townley, Rohan Hazra, Kathy George, Cindy Vavro, Theodore Ruel, Edward Acosta, IMPAACT P1093 Team, Hardik Chandasana, Rajendra Singh, Annie Buchanan, Cynthia Brothers, Andy Wiznia, Mattie Bartlett, Stephanie Popson. Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics. PMID: 38768443Study
P1093
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy
Citation
Murli Purswani, Allison Bearden, Andrew Wiznia, Allison Agwu, Thor A. Wagner, Ellen G. Chadwick, Camlin Tierney, Douglas Richman, Sharon Huang, Monica Gandhi, Sharon Nichols, Patrick Mehta, Kathleen M. Malee, Bernard Macatangay, Nicole A. Montañez, Stephen A. Spector, Anne Coletti, Serena Spudich, Hans ML Spiegel, Deborah Persaud, Chelsea Krotje, Ann Chahroudi, Frederic Bone, IMPAACT 2015 Protocol Team, Megan Wilkins, Lisa Abuogi. Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy. AIDS. 38: 1494-1504. PMID: 38814693Journal
AIDS
Study
IMPAACT 2015
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Citation
Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R. Cressey, Edward P. Acosta, Kristina M. Brooks, IMPAACT 2019 Study Team, Hardik Chandasana, Sven C. van Dijkman. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious Diseases and Therapy. PMID: 38961048Journal
Infectious Diseases and Therapy
Study
IMPAACT 2019